CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
3 research outputs found
Nanosuspension-based formulation development for the first-in-class PLK2 inhibitor, GBO-006, toward IND-enabling studies.
Author
Arnab Roy Chowdhury
Jeyaraj Duraiswamy Athisayamani
Seetaraju Gembali
Srinivas Rao Maddi
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
A Validated Chiral LC Method for the Enantiomeric Separation of Nateglinide and the Quantitative Determination of Its l-Enantiomer
Author
AH Karara
B. M. Rao
+17Â more
CJ Dunn
DL Massart
G Sridhar
G Yang
G Yang
J Yin
JM Green
L Keilson
ME Swartz
N Yoshikazu
N. Someswara Rao
QI Meiling
S Fujitani
S Fujitani
S Maddi
S. Sangaraju
T. Srinivas
Publication venue
'Springer Fachmedien Wiesbaden GmbH'
Publication date
Field of study
No full text
Crossref
Evidence of stereoselective and segmental-dependant transport of chiral antidiabetic drug nateglinide along the rat small intestine: possible role of efflux transporters
Author
A Dornhost
A Garrigues
+30Â more
A Okamura
Adukondalu Devandla
AE Trezise
AT Fojo
CJ Halas
CL Cummins
D Devineni
G Fricker
Gerhard Scriba
H Koepsell
H Shinkai
J Chinale
JH Hochman
LP Ruan
LZ Benet
LZ Benet
LZ Benet
Madhusudan Rao Yamsani
MF Fromm
MF Fromm
ML Weaver
PB Watkins
R Yumoto
S Drescher
S Hu
Shravan Kumar Yamsani
Srinivas Maddi
T Inoue
T Litman
VJ Wacher
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref